Uses of Biomaterials and Biocompatible Materials
Abstract
Full Text:
PDFReferences
Chen Q, Thouas GA. Metallic implant biomaterials. Materials Science and Engineering: R: Reports. 2015; 87:1-57.
Patel NR, Gohil PP. A review on biomaterials: scope, applications & human anatomy significance. International Journal of Emerging Technology and Advanced Engineering.2012;2(4):91-101.
Davis JR. Overview of biomaterials and their use in medical devices. Handbook of materials for medical devices. 2003:1-1.
Navarro M, Michiardi A, Castano O, Planell JA. Biomaterials in orthopaedics. Journal of the royal society interface. 2008;5(27):1137-58.
Thorne SH, Negrin RS, Contag CH. Synergistic antitumor effects of immune cell-viral biotherapy. Science. 2006;311(5768):1780-4.
Gretch D. Editorial commentary: advocating the concept of GB virus C biotherapy against AIDS. Clinical infectious diseases. 2012;55(7):1020-1.
Naji A, Rouas-Freiss N, Durrbach A, Carosella ED, Sensébé L, Deschaseaux F. Concise review:combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy. Stem cells. 2013 ;31(11):2296-303
Van Rooij E, Olson EN. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nature reviews Drug discovery. 2012;11(11):860-72.
Jieheng W, Angang Y, Weihong W. Current status of bench-to-bedside translation of cancer therapeutic antibodies. Chinese Journal of Cancer Biotherapy. 2014;21(3):325-33.
Abdelbary H, Brown CW, Werier J, Bell J. Using targeted virotherapy to treat a resistant Ewing sarcoma model: From the bedside to the bench and back. The Scientific World Journal. 2014;2014.
Uckun FM. Monoclonal Antibody (mAb)-Based Biotherapy Options for B-lineage Non-Hodgkin’s Lymphoma (NHL). Transl Med 3: e118. doi: 10.4172/2161-1025.1000 e118 Page 2 of 2
Radioimmunotherapy and anti-CD20 immunotherapy in non-Hodgkin lymphom a (NHL): Phase I results. In54th ASH Annual Meeting, San Diego, CA, Abstrac 2013 (Vol. 3680, p. 12).
Chen X, Lin X, Zhao J, Shi W, Zhang H, Wang Y, Kan B, Du L, Wang B, Wei Y, Liu Y. A tumorselective biotherapy with prolonged impact on established metastases based on cytokine geneengineered MSCs. Molecular Therapy. 2008;16(4):749-56.
Su X, Zhang L, Jin L, Ye J, Guan Z, Chen R, Guo T. Immunotherapy with cytokine-induced killer cells in metastatic renal cell carcinoma. Cancer biotherapy & radiopharmaceuticals.
;25(4):465-70.
Niidome T, Huang L. Gene therapy progress and prospects: nonviral vectors. Gene therapy. 2002Dec;9(24):1647-52.
Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature. 2001;411(6835):380-4.
Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature. 2008 Feb;451(7181):937-42.
Huang X, Liu D, Liu K et al 2006 Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies Bone Marrow Transpl. 8
-7
Refbacks
- There are currently no refbacks.